Literature DB >> 11865076

Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression?

Jerome Rossert, William M McClellan, Simon D Roger, Dierik L Verbeelen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11865076     DOI: 10.1093/ndt/17.3.359

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  4 in total

1.  The epidemiological association of altitude with chronic kidney disease: Evidence of protective effect.

Authors:  Nasrollah Ghahramani; Faris Ahmed; Ammar Al-Laham; Eugene J Lengerich
Journal:  Nephrology (Carlton)       Date:  2011-02       Impact factor: 2.506

Review 2.  [Therapy and prophylaxis of renal failure].

Authors:  V M Brandenburg; B Heintz; J Floege
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

3.  [Can the progression of chronic renal failure be delayed?].

Authors:  U Kuhlmann; J Hoyer
Journal:  Internist (Berl)       Date:  2008-04       Impact factor: 0.743

4.  Recombinant human epoetin beta in the treatment of renal anemia.

Authors:  Francesco Locatelli; Pietro Pozzoni; Lucia Del Vecchio
Journal:  Ther Clin Risk Manag       Date:  2007-06       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.